Sign inJoin waitlistJoin the waitlist

Ramaswamy Govindan

The Anheuser Busch Endowed Chair in Medical Oncology and Chief of the Section of Medical Oncology · Washington Univ Sch of Med

Credentials: · · ·

History

section of medical oncology · Washington Univ Sch of Med
Present
Oncology · Washington University/B-JH/SLCH Consortium
Present
Washington Univ Sch of Med
Present

Medical Oncology
1989–1991
Internal Medicine
1986–1989
Stanley Med Clg Univ Madras
1982–1986

Research

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
Nature · 2019 · 1,832 citations
Sex and gender: modifiers of health, disease, and medicine
Review · The Lancet · 2020 · 1,545 citations
Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database
Journal of Clinical Oncology · 2006 · First of 8 authors · Corresponding · 1,522 citations

DM
Daniel Morgensztern
70 papers
Saima Waqar
44 papers
Siddhartha Devarakonda
43 papers · 12 as a fellow
JS
Janakiraman Subramanian
27 papers · 16 as a resident
MB
Maria Baggstrom
21 papers
Jeff Bradley
19 papers
Jyoti Patel
19 papers
Wallace Akerley
18 papers
LH
Leora Horn
17 papers
Li Ding
17 papers
GO
Gregory Otterson
16 papers
GR
Gregory Riely
16 papers · 2 as a fellow

Grants

Washington University PDX Development and Trial Center
National Cancer Institute · U54
Contact PI · $11.9M · Washington University
2017–2028
Proteogenomic Predictors of Recurrence in Non-Small Cell Lung Cancer
National Cancer Institute · U01
Contact PI · $5M · Washington University
2022–2027
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
National Cancer Institute · K12
Contact PI · $11.7M · Washington University
2012–2027
Deep Exploration of Drivers, Evolution, and Microenvironment Toward Discovering Principal Themes in Cancer
National Cancer Institute · U24
PI · $1.8M · Washington University
2021–2026

Clinical trials

Small Cell Lung Cancer Irinotecan and CDC2-like Kinase Inhibition Trial (SLICK Trial)
Principal investigator · Recruiting · Phase 1, Phase 2
Washington University School of Medicine
2025–2029
Personalized Therapeutic Anti-tumor Vaccine With Pembrolizumab and Standard of Care Chemotherapy in Squamous Non-Small Cell Lung Cancer and Extensive Stage Small Cell Lung Cancer
Principal investigator · Withdrawn · Phase 1
Washington University School of Medicine
2019–2027
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
Principal investigator · Terminated · Phase 2
Washington University School of Medicine
2016–2018
Concordance of Inivata Liquid Biopsy With Standard of Care Tissue Testing
Principal investigator · Completed
Inivata
2016–2018